You are here: BCU: Her2 Testing in Breast Cancer Management: Faculty  


Mark Pegram, MD
Associate Professor of Medicine
David Geffen School of Medicine at UCLA
Director, Women's Cancer Program
UCLA/Jonsson Comprehensive Cancer Center

   


Edith A Perez, MD
Professor of Medicine
Mayo Medical School
Chair, NCCTG Breast Cancer Committee

   


Michael F Press, MD, PhD
Harold E Lee Chair in Cancer Research
Professor, Department of Pathology
University of Southern California

   


Ann D Thor, MD
Lloyd E Rader Professor and Chair of Pathology
Adjunct Professor of Surgery
Associate Director for Translational Research
Program Director for Breast Cancer Program
University of Oklahoma Cancer Center

   

 

Table of Contents Top of Page
Table of contents
 
CME Information
Editor’s Note:
Getting It Right
Faculty

Concordance Between Local and Central Laboratory HER2 Testing
- Related publications

Comparison of HER2 Assays
- Related publications
Concordance of HER2 Status Between Primary and Metastatic Lesions
- Related publications
HER2 Status and Response to Trastuzumab
- Related publications
College of American Pathologists
 - Related publications
 
Faculty Disclosures
Home · Contact us
Terms of use and general disclaimer